Mon05202019

Robins Global News & Noticias



  • Shipping Advice
    Shipping Advice
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update


LA JOLLA, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today reported its financial results and is providing a business update for the first quarter ended March 31, 2019.
Corporate Highlights in 2019:First biotechnology company to close initial public offering in 2019 and commence trading on The Nasdaq Capital Market.Received the Part the Cloud Award from the Alzheimer’s Association, including a $1 million grant to advance XPro1595, a novel therapy targeting neuroinflammation as a cause of Alzheimer’s disease.“2019 has marked a transformative period for INmune Bio, as the first biotech of the year to close its IPO and list on the Nasdaq,” stated RJ Tesi, M.D., Chief Executive Officer of INmune Bio. “We are focused on advancing our clinical programs for the foreseeable future.” Our clinical programs continue to advance:INB03, our program targeting resistance to immunotherapy caused by myeloid derived suppressor ells (MDSC), completing a monotherapy Phase I trial in patients with advanced solid tumors, will transition into a combination therapy clinical program this summer in preparation for a Phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC that should begin in 2020.  INB03 targets MDSC - one of the causes of resistance to checkpoint inhibitors.  Treatment with INB03 should eliminate the MDSC in the tumor microenvironment to allow CPI to be therapeutically effective.INKmune, our NK cell therapy focused on eliminating residual disease after cancer therapy will start enrolling patients in a Phase I/II trial in women with relapsed refractory ovarian cancer later this year.  In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of their NK cells to eliminate minimal residual disease (MRD).  INKmune, by priming the patient’s NK cells to attack their tumor, should eliminate MRD to prevent relapse.


Posted: 2019-05-15 13:03:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.


Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

SWK Holdings Corporation Announces 2019 First Quarter Financial Results

Wed, 15 May 2019 18:29:00 GMT

DALLAS, May 15, 2019 (GLOBE NEWSWIRE) -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced its first quarter 2019 financial ...

INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update

Wed, 15 May 2019 06:08:00 GMT

“2019 has marked a transformative period for INmune Bio, as the first biotech of the year to close its IPO and list on the Nasdaq,” stated RJ Tesi, M.D., Chief Executive Officer of INmune Bio. “We are ...

Aqua Metals, Inc. (AQMS) CEO Steve Cotton on Q1 2019 Results - Corporate Update Call Transcript

Tue, 14 May 2019 16:02:00 GMT

Aqua Metals, Inc. (NASDAQ:AQMS) Q1 2019 Corporate Update Call May 14 ... Last Thursday Aqua Metals released financial results for the quarter ended March 31, 2019. This release is available ...

STRATA Skin Sciences Announces Preliminary First Quarter 2019 Financial Results and Updates

Tue, 14 May 2019 05:05:00 GMT

Financial results reported in this press release are preliminary ... During the quarter ended March 31, 2019, a shareholder converted 3,090 shares of Series C Preferred Stock into 1,148,698 shares of ...

Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update

Tue, 14 May 2019 02:15:00 GMT

today announced financial results for the first quarter ended March 31, 2019 and provided a business update. "We made great progress in the first quarter, as we executed on our strategy and worked to ...

Related Bing Web Search

Financial Results | BOQ

(Wed, 15 May 2019 09:10:00 GMT)

2017. Full year results. BOQ announced a statutory profit of $352 million for the 2017 financial year. View the announcement via webcast.. Investor information

2019 Financial Results / Investors / Capital Drilling

(Sat, 18 May 2019 01:42:00 GMT)

Corporate Head Office Capital Drilling Limited The CORE Building 9th Floor Ébène CyberCity Mauritius. Telephone +230 464 3250 Fax +230 464 3255 Email info@capdrill.com

2019 financial calendar - Shareholder centre - NAB

(Fri, 17 May 2019 11:23:00 GMT)

Mark the important dates in NAB's 2018 financial calendar to get an overview of relevant financial publication and stay updated.

BMO Financial Group Reports First Quarter 2019 Results

(Fri, 17 May 2019 19:37:00 GMT)

Financial Results Highlights First Quarter 2019 Compared With First Quarter 2018: Net income1 of $1,510 million, up 55%; adjusted net income2 of $1,538 million, up 8% Net revenue3,4 of $5,591...

TI reports 1Q19 financial results and shareholder returns

(Wed, 07 Mar 2018 23:57:00 GMT)

Revenue decreased due to High Volume and Power, partially offset by an increase in Signal Chain. Operating profit decreased due to lower revenue and reduced factory loadings. Embedded Processing ...

CleanSpark Releases Shareholder Update Letter March 2019

(Thu, 07 Mar 2019 23:53:00 GMT)

To our Stakeholders; I would like to begin by thanking all of you for your continued support. I am pleased to report to you on our 2019 year to date progress and share our outlook for the balance ...

Aphria Announces Third Quarter Fiscal 2019 Financial Results

(Thu, 16 May 2019 04:51:00 GMT)

Net revenue for the three months ended February 28, 2019 was $73.6 million, compared to $21.7 million in the prior quarter and $10.3 million in the same period last year. Higher revenue in the ...

Nova to Report First Quarter 2019 Financial Results on May 1, 2019 - prnewswire.com

(Fri, 17 May 2019 23:12:00 GMT)

REHOVOT, Israel, April 4, 2019 /PRNewswire/ -- Nova (NASDAQ: NVMI), announced today that it will release its results for the first quarter of 2019 before the Nasdaq market opens on Wednesday, May ...

Financial results | CYBG

(Fri, 17 May 2019 13:39:00 GMT)

Financial results Listed Company Accounts. Financial results prior to 2016 relate to published accounts for Clydesdale Bank before becoming a listed company.

Finisar Announces Third Quarter of Fiscal 2019 Financial Results | FINISAR CORPORATION - investor.finisar.com

(Thu, 16 May 2019 05:34:00 GMT)

SUNNYVALE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Finisar Corporation (NASDAQ: FNSR), a global technology leader for subsystems and components for fiber optic communications, today announced financial results for third quarter of fiscal 2019, ended January 27, 2019. Finisar will not hold an earnings call, nor provide forward guidance for the fourth quarter of fiscal 2019 due to the ...

Related News Story Videos From Youtube

Warren Buffett and Charlie Munger chair the 2019 Berkshire Hathaway Shareholders Meeting (FULL)


Related Videos On: Warren Buffett and Charlie Munger chair the 2019 Berkshire Hathaway Shareholders Meeting (FULL)


Tesla Q1 2019 Earnings Call (no ads)


Related Videos On: Tesla Q1 2019 Earnings Call (no ads)


Tesla Q3 2018 Earnings Call - Financial Results and Q&A Webcast [LIVE]


Related Videos On: Tesla Q3 2018 Earnings Call - Financial Results and Q&A Webcast [LIVE]


Tesla 2018 Q4 Earnings Call (No Ads)


Related Videos On: Tesla 2018 Q4 Earnings Call (No Ads)


Financial Results Q1 2019


Related Videos On: Financial Results Q1 2019






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.